Reduced disease‐specific survival following a diagnosis of multiple primary cutaneous malignant melanomas—a nationwide, population‐based study-Reference-Cited by-同舟云学术

Reduced disease‐specific survival following a diagnosis of multiple primary cutaneous malignant melanomas—a nationwide, population‐based study

Published:2017-08-24 Issue:11 Volume:141 Page:2243-2252
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Utjés Deborah¹²^ORCID,Lyth Johan³,Lapins Jan⁴,Eriksson Hanna¹²

Affiliation:

1. Department of Oncology‐PathologyKarolinska InstitutetStockholm Sweden

2. Department of OncologyKarolinska University HospitalStockholm Sweden

3. Research and Development Unit in Region Östergötland and Department of Medical and Health SciencesLinköping UniversityLinköping Sweden

4. Unit of Dermatology, Karolinska University HospitalStockholm Sweden

Funder

Swedish Cancer Society

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.30925

Reference33 articles.

1. FerlayJSI ErvikM DikshitR et al. GLOBOCAN 2012 v1.0 cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet) Lyon France: International Agency for Research on Cancer 2013. Available at:http://globocan.iarc.fr accessed on 07/10/2015.

2. Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men

3. Second primary melanomas: incidence and outcome;Bower MR;Am Surg,2010

4. A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors

5. Clinical and prognostic reports from 270 patients with multiple primary melanomas: a 34-year single-institution study

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malignant features of minipig melanomas prior to spontaneous regression;Scientific Reports;2024-04-22

2. Survival in melanoma in the nordic countries into the era of targeted and immunological therapies;European Journal of Cancer;2023-06

3. Melanoma‐specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non‐carriers;Journal of the European Academy of Dermatology and Venereology;2022-10

4. Types of second primary cancer influence overall survival in cutaneous melanoma;BMC Cancer;2021-10-19

5. Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis;Cell Death & Disease;2021-05